Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 59

1.

DRD1 associations with smoking abstinence across slow and normal nicotine metabolizers.

Lee W, Ray R, Bergen AW, Swan GE, Thomas P, Tyndale RF, Benowitz NL, Lerman C, Conti DV.

Pharmacogenet Genomics. 2012 Jul;22(7):551-4. doi: 10.1097/FPC.0b013e3283539062.

2.

Nicotine dependence as a moderator of genetic influences on smoking cessation treatment outcome.

Leventhal AM, Lee W, Bergen AW, Swan GE, Tyndale RF, Lerman C, Conti DV.

Drug Alcohol Depend. 2014 May 1;138:109-17. doi: 10.1016/j.drugalcdep.2014.02.016. Epub 2014 Mar 5.

3.

Drug Metabolizing Enzyme and Transporter Gene Variation, Nicotine Metabolism, Prospective Abstinence, and Cigarette Consumption.

Bergen AW, Michel M, Nishita D, Krasnow R, Javitz HS, Conneely KN, Lessov-Schlaggar CN, Hops H, Zhu AZ, Baurley JW, McClure JB, Hall SM, Baker TB, Conti DV, Benowitz NL, Lerman C, Tyndale RF, Swan GE; Transdisciplinary Research in Cancer of the Lung Research Team.

PLoS One. 2015 Jul 1;10(7):e0126113. doi: 10.1371/journal.pone.0126113. eCollection 2015.

4.

Decreased Nicotinic Receptor Availability in Smokers with Slow Rates of Nicotine Metabolism.

Dubroff JG, Doot RK, Falcone M, Schnoll RA, Ray R, Tyndale RF, Brody AL, Hou C, Schmitz A, Lerman C.

J Nucl Med. 2015 Nov;56(11):1724-9. doi: 10.2967/jnumed.115.155002. Epub 2015 Aug 13.

5.

Precision Medicine for Tobacco Dependence: Development and Validation of the Nicotine Metabolite Ratio.

Allenby CE, Boylan KA, Lerman C, Falcone M.

J Neuroimmune Pharmacol. 2016 Sep;11(3):471-83. doi: 10.1007/s11481-016-9656-y. Epub 2016 Feb 12. Review.

6.

Gender-stratified gene and gene-treatment interactions in smoking cessation.

Lee W, Bergen AW, Swan GE, Li D, Liu J, Thomas P, Tyndale RF, Benowitz NL, Lerman C, Conti DV.

Pharmacogenomics J. 2012 Dec;12(6):521-32. doi: 10.1038/tpj.2011.30. Epub 2011 Aug 2.

7.

Brain Responses to Smoking Cues Differ Based on Nicotine Metabolism Rate.

Falcone M, Cao W, Bernardo L, Tyndale RF, Loughead J, Lerman C.

Biol Psychiatry. 2016 Aug 1;80(3):190-7. doi: 10.1016/j.biopsych.2015.11.015. Epub 2015 Nov 26.

8.

Association between nicotinic acetylcholine receptor single nucleotide polymorphisms and smoking cessation.

Spruell T, Colavita G, Donegan T, Egawhary M, Hurley M, Aveyard P, Johnstone EC, Murphy MF, Munafò MR.

Nicotine Tob Res. 2012 Aug;14(8):993-7. doi: 10.1093/ntr/ntr246. Epub 2011 Dec 17.

PMID:
22180580
9.

Dopamine-related genes and spontaneous smoking cessation in ever-heavy smokers.

Breitling LP, Müller H, Illig T, Rujescu D, Winterer G, Dahmen N, Nitz B, Raum E, Rothenbacher D, Brenner H.

Pharmacogenomics. 2011 Aug;12(8):1099-106. doi: 10.2217/pgs.11.74. Epub 2011 Aug 1.

PMID:
21806388
10.

Association of the nicotine metabolite ratio and CHRNA5/CHRNA3 polymorphisms with smoking rate among treatment-seeking smokers.

Falcone M, Jepson C, Benowitz N, Bergen AW, Pinto A, Wileyto EP, Baldwin D, Tyndale RF, Lerman C, Ray R.

Nicotine Tob Res. 2011 Jun;13(6):498-503. doi: 10.1093/ntr/ntr012. Epub 2011 Mar 8.

11.

Association of polymorphisms in the BDNF, DRD1 and DRD3 genes with tobacco smoking in schizophrenia.

Novak G, LeBlanc M, Zai C, Shaikh S, Renou J, DeLuca V, Bulgin N, Kennedy JL, Le Foll B.

Ann Hum Genet. 2010 Jul;74(4):291-8. doi: 10.1111/j.1469-1809.2010.00578.x. Epub 2010 Apr 25.

12.

Nicotine Metabolite Ratio (NMR) Prospectively Predicts Smoking Relapse: Longitudinal Findings From ITC Surveys in Five Countries.

Fix BV, O'Connor RJ, Benowitz N, Heckman BW, Cummings KM, Fong GT, Thrasher JF.

Nicotine Tob Res. 2017 Sep 1;19(9):1040-1047. doi: 10.1093/ntr/ntx083.

PMID:
28387850
13.

Molecular genetics of nicotine dependence and abstinence: whole genome association using 520,000 SNPs.

Uhl GR, Liu QR, Drgon T, Johnson C, Walther D, Rose JE.

BMC Genet. 2007 Apr 3;8:10.

14.

A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.

Robles GI, Singh-Franco D, Ghin HL.

Clin Ther. 2008 May;30(5):800-12. doi: 10.1016/j.clinthera.2008.05.010. Review.

PMID:
18555928
15.

An association study of DRD5 with smoking initiation and progression to nicotine dependence.

Sullivan PF, Neale MC, Silverman MA, Harris-Kerr C, Myakishev MV, Wormley B, Webb BT, Ma Y, Kendler KS, Straub RE.

Am J Med Genet. 2001 Apr 8;105(3):259-65.

PMID:
11353446
16.

Smoking cessation pharmacogenetics: analysis of varenicline and bupropion in placebo-controlled clinical trials.

King DP, Paciga S, Pickering E, Benowitz NL, Bierut LJ, Conti DV, Kaprio J, Lerman C, Park PW.

Neuropsychopharmacology. 2012 Feb;37(3):641-50. doi: 10.1038/npp.2011.232. Epub 2011 Nov 2.

17.

[Nicotine dependence].

Kawazoe S, Shinkai T.

Nihon Rinsho. 2015 Sep;73(9):1516-21. Review. Japanese.

PMID:
26394514
18.

Common polymorphisms in FMO1 are associated with nicotine dependence.

Hinrichs AL, Murphy SE, Wang JC, Saccone S, Saccone N, Steinbach JH, Goate A, Stevens VL, Bierut LJ.

Pharmacogenet Genomics. 2011 Jul;21(7):397-402. doi: 10.1097/FPC.0b013e328346886f.

19.

Genetic variation in three candidate genes and nicotine dependence, withdrawal and smoking cessation in hospitalized patients.

De Ruyck K, Nackaerts K, Beels L, Werbrouck J, De Volder A, Meysman M, Salhi B, Van Meerbeeck J, Thierens H.

Pharmacogenomics. 2010 Aug;11(8):1053-63. doi: 10.2217/pgs.10.75.

PMID:
20712524
20.

Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial.

Koegelenberg CF, Noor F, Bateman ED, van Zyl-Smit RN, Bruning A, O'Brien JA, Smith C, Abdool-Gaffar MS, Emanuel S, Esterhuizen TM, Irusen EM.

JAMA. 2014 Jul;312(2):155-61. doi: 10.1001/jama.2014.7195.

PMID:
25005652

Supplemental Content

Support Center